Related Experiment Videos
Development of microfusion techniques to generate human hybridomas
S Foung1, S Perkins, K Kafadar
1Department of Pathology, Stanford University School of Medicine, CA 94305.
Journal of Immunological Methods
|November 6, 1990
Summary
Generating human hybridomas for monoclonal antibodies is now more efficient. This electrofusion technique requires fewer B cells and achieves higher hybridoma formation rates, overcoming rarity limitations.
Area of Science:
- Immunology
- Biotechnology
- Cell Biology
Background:
- Rarity of antigen-specific B cells limits human monoclonal antibody production.
- Existing hybridoma formation techniques require large cell numbers and have suboptimal efficiency.
Purpose of the Study:
- To develop an improved method for generating human hybridomas.
- To increase hybridoma formation efficiency using fewer input B cells.
Main Methods:
- Utilized electrofusion under strongly hypo-osmolar conditions to facilitate cell fusion.
- Optimized electrofusion parameters, including exposure duration to hypo-osmolar solutions.
- Investigated factors affecting hybridoma yield such as electrical field strength and cell ratios.
Main Results:
- Achieved hybridoma formation efficiency greater than 5 x 10(-3) under optimal conditions.
- Required only 1-2 x 10(5) input B cells, a ten-fold reduction.
- Demonstrated efficiency comparable to or better than methods using higher cell numbers.
Conclusions:
- Electrofusion in hypo-osmolar conditions significantly enhances human hybridoma production.
- This microfusion technique reduces the need for rare antigen-specific B cells.
- The optimized method offers a more efficient approach for generating human monoclonal antibodies.